Navigation Links
Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™
Date:2/15/2011

uorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. For more information please visit www.pfenex.com

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. Since it was founded in 1885, the family-owned company has been committed for 125 years to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2009, Boehringer Ingelheim posted net sales of 12.7 billion euro while spending 21% of net sales in its largest business segment Prescription Medicines on research and development.

For more information please visit www.boehringer-ingelheim.com.

Today, Boehringer Ingelheim is one of the world's leading companies for contract development and manufacture of biopharmaceuticals. All types of services from mammalian cell line or microbial strain development to final drug production can be delivered within a one-stop-shop concept. Boehringer Ingelheim delivers services for pre-clinical development up to global market supply with a strong commitment to its customers at its manufacturing facilities for mammalian cell culture and microbial fermentation. Boehringer Ingelheim has brought 18 molecules to market and has  many  years  of  experience  in  multiple  molecule  classes  such  as monoclonal antibodies, recombinant proteins, interferons, enzymes, fusion molecules and plasmid DNA. Furthermore, high-titer platform technologies for new antibody mimetic formats such as scaffold proteins and antibody fragments are available for the manufacture of customer products
'/>"/>

SOURCE Pfenex Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pfenex Grants Exclusive License to Merck & Co., Inc. for the Production of Proteins for Undisclosed Vaccine Program
2. Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen (rPA) From Anthr
3. Pfenex Inc. Establishes Reagent Protein Distribution Agreement With Cedarlane Corporation
4. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
5. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
6. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
7. Boehringer Ingelheim Unveils Diabetes Pipeline
8. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
9. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
10. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
11. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 Reportlinker.com announces that ... its catalogue: Global Orthopedic Soft Tissue ... http://www.reportlinker.com/p02316671/Global-Orthopedic-Soft-Tissue-Repair-Devices-Market-2014-2018.html About Orthopedic Soft ... mass of cells that connect, support, or surround ... tissues such as tendons, ligaments, cartilage, fascia, and ...
(Date:8/27/2014)... , Aug. 27, 2014  Decision Resources ... specialties (medical oncology, hematology-oncology, rheumatology, gastroenterology, endocrinology and ... trials that a biosimilar has been assessed in ... product they choose to prescribe. ... report entitled Acceptance of Biosimilars Across ...
(Date:8/27/2014)... , Aug. 27, 2014 Decision Resources ... characterized the Memphis health system ... to clinical integration, with rivals Methodist Le Bonheur Healthcare ... physician groups to coordinate patient care. In addition, a ... has the most health plan enrollment in the ...
Breaking Medicine Technology:Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2Memphis-area Health Systems Turn Attention to Clinical Integration 2
... CITY, Md., Oct. 11, 2011 Christine K. Pierre, ... a "Professional Woman of the Year" by the National ... recognizes Pierre,s "outstanding leadership and commitment" within her profession, ... women. Pierre founded RxTrials, Inc., in 1994, ...
... Johnson (NYSE: JNJ ) will host a conference ... Tuesday, October 18, 2011, to review third-quarter results.  Dominic Caruso, ... Vice President, Investor Relations, will host the call. ... visiting the Company,s website at www.investor.jnj.com . ...
Cached Medicine Technology:Christine Pierre Selected as "Professional Woman of the Year" 2
(Date:8/27/2014)... Md. (PRWEB) August 27, 2014 ... recently released guidelines for the management and treatment ... Therapy for Pulmonary Arterial Hypertension in Adults: CHEST ... free to view for clinicians, and provide the ... , The Pulmonary Hypertension Association (PHA) ...
(Date:8/27/2014)... By Dennis Thompson ... -- Someone who has been mugged in a dark alley ... location with a fear of being attacked. But neuroscientists ... controls how memories are linked with positive and negative emotions. ... the emotions attached to a memory. In essence, they ...
(Date:8/27/2014)... 2014 Michigan Head & Neck Institute is ... a local elementary school by ensuring they have everything they ... year-round attendance, and Michigan Head & Neck Institute wants to ... school year. , "There are a lot of military families ... way to give back to our community," said Lauren Taylor, ...
(Date:8/27/2014)... York, New York (PRWEB) August 27, 2014 ... hip lawsuits ( http://www.consumerinjurylawyers.com/DePuy/ ) has extended the deadline ... According to an August 2014 Order issued by U.S. ... Ohio, those wishing to enroll in the DePuy ASR ... (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products ...
(Date:8/27/2014)... glass of wine at a time may keep you from drinking ... college students and staff to pour red and white wines in ... in them. The participants were told to pour an amount they ... how much to pour -- such as limiting it to half ... wine than those without set guidelines. "About 70 percent of ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults 2Health News:Scientists 'Rewrite' Bad Memories in Mice 2Health News:Scientists 'Rewrite' Bad Memories in Mice 3Health News:Michigan Head & Neck Institute is Conducting Their 2nd Annual School Supplies Drive at Their Facility to Benefit Local Year-Round Elementary School Students 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:'Half a Glass' Rule May Curb Overdrinking 2
... the word "vacation" may conjure images of leisurely, carefree ... to published research by a University of Illinois expert ... the fastest growing markets in vacation travel because it ... the realm of personal enrichment and fulfillment. The ...
... ... February 28th, issued an email entitled "Fear Not!" , ... Pensacola, FL (PRWEB) March 4, 2010 -- ... issued an email entitled "Fear Not!" "We received a message from one of our ...
... ... ... ... ...
... ... ... ... ...
... of cancer death among men and women nationwide, yet ... it. The American Gastroenterological Association (AGA) Institute is working ... to encourage everyone age 50 and older to get ... insurance have limited access to screening, gastroenterologists and physicians ...
... advanced tools to see the human brain at work, a ... a product,s appeal while it is still being designed, according ... and Emory University. So-called "neuromarketing" takes the tools of ... to the somewhat abstract likes and dislikes of customer decision-making. ...
Cached Medicine News:Health News:Genealogical tourism redefining leisure travel market, professor says 2Health News:Genealogical tourism redefining leisure travel market, professor says 3Health News:The Power of Prayer Deterred Tsunami's Destruction Ministry Reports 2Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 2Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 3Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 4Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 5Health News:United Nations Secretary-General Ban Ki-moon, President Bill Clinton, Launch MASSIVEGOOD, a Citizen Solution for Funding Global Health 2Health News:United Nations Secretary-General Ban Ki-moon, President Bill Clinton, Launch MASSIVEGOOD, a Citizen Solution for Funding Global Health 3Health News:United Nations Secretary-General Ban Ki-moon, President Bill Clinton, Launch MASSIVEGOOD, a Citizen Solution for Funding Global Health 4Health News:United Nations Secretary-General Ban Ki-moon, President Bill Clinton, Launch MASSIVEGOOD, a Citizen Solution for Funding Global Health 5Health News:United Nations Secretary-General Ban Ki-moon, President Bill Clinton, Launch MASSIVEGOOD, a Citizen Solution for Funding Global Health 6Health News:Physicians come together on National Colorectal Cancer Awareness and Screening Day 2
... Esteem™ External Vacuum Therapy System restores sexual ... men. Non-invasive and low cost vacuum therapy, ... desirable outcome", makes it the ideal therapy ... Therapy System causes penile rigidity that can ...
Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand....
... D.O.R.C. Associate is an advanced ophthalmic ... and Venturi pump, allowing surgeons to ... Phaco or Vitrectomy procedures.,The key feature ... microprocessor-controlled vacuum system that measures in-line ...
... D.O.R.C. Harmony Total TTC® is a complete ... vitreoretinal surgery. Color coded function modes with ... compact design assures an easy to operate ... linear function footswitch provides the surgeon complete ...
Medicine Products: